Frontier Medicines Corp — Form D/A
Frontier Medicines Corp of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2020-11-06. The offering totals $67.0M, of which $67.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-11-06
- Form: D/A
- Accession: 0001567619-20-018769
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $67.0M
- Amount sold: $67.0M
- Remaining: $1
- Investors: 31
- Date of first sale: 2019-04-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-345214
Issuer
- Name: Frontier Medicines Corp
- CIK: 0001783380
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 151 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-457-1005
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Luke Evnin | Director | Watertown, MA |
| Cameron Wheeler | Director | Cambridge, MA |
| Janwillem Naesens | Director | San Francisco, CA |
| Othman Laraki | Director | Burlingame, CA |
| Jim Winkler | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Johannes Hermann, Ph.D. | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Kevin Webster | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Gregory Chow | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Chris Varma, Ph.D. | Director | SOUTH SAN FRANCISCO, CA |
| Chris Varma, Ph.D. | Executive Officer | SOUTH SAN FRANCISCO, CA |
Other filings by this issuer (2)
More